Atossa Genetics Inc

NASDAQ: ATOS
$1.49
+$0.07 (+4.9%)
Closing price April 23, 2024
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.
The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions. Here's a look going into this trading session.